IL324435A - נוגדנים נגד-איי אל1אר איי פי - Google Patents
נוגדנים נגד-איי אל1אר איי פיInfo
- Publication number
- IL324435A IL324435A IL324435A IL32443525A IL324435A IL 324435 A IL324435 A IL 324435A IL 324435 A IL324435 A IL 324435A IL 32443525 A IL32443525 A IL 32443525A IL 324435 A IL324435 A IL 324435A
- Authority
- IL
- Israel
- Prior art keywords
- il1rap antibodies
- il1rap
- antibodies
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23171919 | 2023-05-05 | ||
| PCT/EP2024/062207 WO2024231251A1 (en) | 2023-05-05 | 2024-05-03 | Anti-il1rap antibodies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL324435A true IL324435A (he) | 2026-01-01 |
Family
ID=86330201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL324435A IL324435A (he) | 2023-05-05 | 2025-11-04 | נוגדנים נגד-איי אל1אר איי פי |
Country Status (5)
| Country | Link |
|---|---|
| KR (1) | KR20260007604A (he) |
| CN (1) | CN121263442A (he) |
| AU (1) | AU2024270136A1 (he) |
| IL (1) | IL324435A (he) |
| WO (1) | WO2024231251A1 (he) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026022232A1 (en) | 2024-07-24 | 2026-01-29 | Almirall, S.A. | Il-1rap inhibitor for treating or preventing hidradenitis suppurativa |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| SE459005B (sv) | 1985-07-12 | 1989-05-29 | Aake Rikard Lindahl | Saett att framstaella sfaeriska polymerpartiklar |
| CA2192782C (en) | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production of microspheres |
| ES2601882T5 (es) | 1999-04-09 | 2021-06-07 | Kyowa Kirin Co Ltd | Procedimiento para controlar la actividad de una molécula inmunofuncional |
| US7960512B2 (en) | 2003-01-09 | 2011-06-14 | Macrogenics, Inc. | Identification and engineering of antibodies with variant Fc regions and methods of using same |
| JP5055603B2 (ja) | 2004-08-04 | 2012-10-24 | メントリック・バイオテック・リミテッド・ライアビリティ・カンパニー | 変異Ｆｃ領域 |
| GB2472856B (en) | 2009-08-21 | 2012-07-11 | Cantargia Ab | IL1-RAP modulators and uses thereof |
| MX354450B (es) | 2011-01-19 | 2018-03-05 | Cantargia Ab | Anticuerpos anti proteína accesoria del receptor de interleucina-1 y su uso para tratamiento en humanos. |
| GB201403875D0 (en) * | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
| JP2022532812A (ja) * | 2018-08-16 | 2022-07-20 | カンタージア アクチエボラーグ | 抗ｉｌ１ｒａｐ抗体組成物 |
| AU2021405730A1 (en) | 2020-12-23 | 2023-07-06 | Otsuka Pharmaceutical Co., Ltd. | Anti-il1rap antibody |
-
2024
- 2024-05-03 AU AU2024270136A patent/AU2024270136A1/en active Pending
- 2024-05-03 CN CN202480037770.5A patent/CN121263442A/zh active Pending
- 2024-05-03 WO PCT/EP2024/062207 patent/WO2024231251A1/en active Pending
- 2024-05-03 KR KR1020257040025A patent/KR20260007604A/ko active Pending
-
2025
- 2025-11-04 IL IL324435A patent/IL324435A/he unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20260007604A (ko) | 2026-01-14 |
| WO2024231251A1 (en) | 2024-11-14 |
| AU2024270136A1 (en) | 2025-11-20 |
| CN121263442A (zh) | 2026-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE069018T2 (hu) | Anti-CCR8 antitestek | |
| GB2614651B (en) | Antibodies | |
| IL324435A (he) | נוגדנים נגד-איי אל1אר איי פי | |
| GB2627309B (en) | Antibodies | |
| IL317231A (he) | נוגדנים נגד bcma | |
| GB202304512D0 (en) | Antibodies | |
| GB202217924D0 (en) | Antibodies | |
| GB202309981D0 (en) | Antibody | |
| GB202204159D0 (en) | Antibodies | |
| GB202102227D0 (en) | Antibodies | |
| IL325202A (he) | נוגדנים נגד סיבים (פיברילים) | |
| IL320725A (he) | נוגדנים אנטי-בתא-קטנין | |
| GB202400120D0 (en) | Anti-pgdh antibodies | |
| GB202319255D0 (en) | Anti-UNC5C antibodies | |
| GB202318820D0 (en) | Antibodies | |
| GB202317371D0 (en) | Anti-unc5c antibodies | |
| GB202317192D0 (en) | Anti-agr2 antibodies | |
| GB202317189D0 (en) | Anti-AGR2 antibodies | |
| GB202317188D0 (en) | Anti-AGR2 antibodies | |
| GB202317187D0 (en) | Anti-AGR2 antibodies | |
| GB202316016D0 (en) | Antibodies | |
| GB202311473D0 (en) | Anti-ifnl1/reg3a antibodies | |
| GB202311470D0 (en) | Anti-BST2 antibodies | |
| GB202309920D0 (en) | Antibodies | |
| GB202308898D0 (en) | Anti-fibril antibodies |